Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shahane

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Increased Retention in Care After a Palliative Care Referral Among People Living With HIVElizabeth A Gilliams, Rachel J Ammirati, Minh L T Nguyen, et al.
Nature Communications|January 27, 2016
Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterizationRuili Huang, Menghang Xia, Srilatha Sakamuru, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1996
Delayed hypersensitivity skin tests and subsequent renal transplant outcomeP Kumar, J J Thompson, D J Frey, et al.
Arthritis and Rheumatism|February 29, 2000
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study GroupC Hawkey, L Laine, T Simon, et al.
Mutagenesis|August 6, 2015
Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platformKana Nishihara, Ruili Huang, Jinghua Zhao, et al.
Journal of Clinical Pharmacology|September 3, 1999
Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteersM Depré, A Van Hecken, R Verbesselt, et al.
Analytical Biochemistry|July 9, 2009
A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channelSteven A Titus, Daniel Beacham, Sampada A Shahane, et al.
Toxicology and Applied Pharmacology|March 3, 2011
Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channelsMenghang Xia, Sampada A Shahane, Ruili Huang, et al.
DNA Repair|May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platformJunko Murai, Christophe Marchand, Sampada A Shahane, et al.
ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Increased Retention in Care After a Palliative Care Referral Among People Living With HIVElizabeth A Gilliams, Rachel J Ammirati, Minh L T Nguyen, et al.
Nature Communications|January 27, 2016
Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterizationRuili Huang, Menghang Xia, Srilatha Sakamuru, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1996
Delayed hypersensitivity skin tests and subsequent renal transplant outcomeP Kumar, J J Thompson, D J Frey, et al.
Arthritis and Rheumatism|February 29, 2000
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study GroupC Hawkey, L Laine, T Simon, et al.
Mutagenesis|August 6, 2015
Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platformKana Nishihara, Ruili Huang, Jinghua Zhao, et al.
Journal of Clinical Pharmacology|September 3, 1999
Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteersM Depré, A Van Hecken, R Verbesselt, et al.
Analytical Biochemistry|July 9, 2009
A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channelSteven A Titus, Daniel Beacham, Sampada A Shahane, et al.
Toxicology and Applied Pharmacology|March 3, 2011
Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channelsMenghang Xia, Sampada A Shahane, Ruili Huang, et al.
DNA Repair|May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platformJunko Murai, Christophe Marchand, Sampada A Shahane, et al.
ACS Chemical Biology|August 24, 2016
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H Oh, et al.
Pageof 4